tirzepatide which company Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity The science of tirzepatide, touted

23 Mounjaro: An injectable approved by the FDA to improve blood sugar control in adults with type 2 diabetes

The different mechanisms offer an alternative approach

They cannot be thrown into your standard domestic household recycling or waste bins

About the TOGETHER-PsO Trial TOGETHER-PsO (NCT06588283) is a 52-week Phase 3b, randomized, multicenter, assessor-blinded, open-label study assessing the efficacy and safety of concomitant administration of Taltz and Zepbound compared with Taltz alone in adult participants with moderate-to-severe plaque psoriasis and obesity or overweight with at least one additional weight-related comorbid condition